Inside this portfolio
Identified stock classes69
Matched (%)99.97%
| Largest reported stocks | Portfolio weight |
|---|---|
| Corcept Therapeutics Inc. | 5.52% |
| Glaukos Corp. | 5.37% |
| Protagonist Therapeutics, Inc. | 4.55% |
| Alkermes PLC | 3.99% |
| TG Therapeutics, Inc. | 3.65% |
How to read these numbers
The day the fund recorded its holdings.
The share of the fund’s net assets that we could identify as common-stock classes.
Holdings history
28 portfolio dates–
Choose a portfolio date to see which stocks had the largest weights then.